• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Post-Authorization Safety Studies of Medicinal Products: The PASS Book

    Post-Authorization Safety Studies of Medicinal Products by Ali, Ayad K.; Hartzema, Abraham G.;

    The PASS Book

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 110.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        45 622 Ft (43 450 Ft + 5% VAT)
      • Discount 10% (cc. 4 562 Ft off)
      • Discounted price 41 060 Ft (39 105 Ft + 5% VAT)

    45 622 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Elsevier Science
    • Date of Publication 19 June 2018

    • ISBN 9780128092170
    • Binding Hardback
    • No. of pages362 pages
    • Size 234x190 mm
    • Weight 910 g
    • Language English
    • 0

    Categories

    Long description:

    Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions.

    Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety.

    More

    Table of Contents:

    1. Introduction
    2. Risk Management Process
    3. Data Sources for PASS
    4. Study Designs for PASS
    5. Analytical Approaches for PASS
    6. Benefit-Risk Evaluation
    7. Other PASS
    8. EU PAS Register

    More
    0